
BPC-157 (10mg) / TB-500 (10mg)
A combined formulation of two extensively researched tissue-repair peptides: BPC-157 (10mg) and TB-500 (10mg). Both compounds appear together in tissue regeneration literature.
About this formulation
This product combines two of the most-studied peptides in tissue repair research into a single vial:
- BPC-157 (10mg) — a synthetic pentadecapeptide derived from human gastric juice, investigated for angiogenesis, anti-inflammatory action, and connective tissue repair
- TB-500 (10mg) — a synthetic fragment of Thymosin Beta-4 investigated for actin regulation, cell migration, and tissue regeneration
Mechanism in Research Literature
The two peptides act through distinct but complementary pathways:
- BPC-157: angiogenesis promotion, GH receptor upregulation, inflammatory cytokine modulation
- TB-500: actin sequestration and reorganization, stem and endothelial cell migration, vascular remodeling
- Combined: research literature describes coverage of both the cellular migration aspect (TB-500) and the inflammatory/angiogenic aspect (BPC-157) of tissue repair
Research Context
This pairing appears in research exploring:
- Connective tissue repair (tendon, ligament, muscle)
- Wound healing dynamics including granulation and revascularization
- Gastric and intestinal mucosa repair
- Vascular remodeling and endothelial function
Related Research Peptides
This formulation sits in literature alongside GHK-Cu, IGF-1 LR3, CJC-1295, and Ipamorelin in the broader tissue-repair research space.
For research and educational use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

